翻訳と辞書 |
Ruthenium anti-cancer drugs : ウィキペディア英語版 | Ruthenium anti-cancer drugs
For the last three decades anticancer chemotherapy has concentrated on cisplatin derivates. In spite of their consistent side effects, cisplatin derivates have a central part in most anticancer treatments. In the search for drugs with fewer side effects other metal complexes have been examined over the past few years. Recent research shows that ruthenium complexes have interesting anticancer properties ''in vivo'' and they might be a good alternative to platinum-based drugs for anticancer therapy. ==Properties==
Ruthenium has numerous properties that qualify it as an antineoplastic drug contender. While platinum-based compounds have served as very successful anti-cancer drugs, they have several limitations including their side effects, as well as ineffectiveness against certain types of cancer. It is thought that some of these issues can be resolved with the use of a ruthenium substitute. Though most ruthenium complexes are only in the beginning stages of become approved anti-cancer drugs, many of their properties give it promising advantages over many platinum based drugs now in use.
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Ruthenium anti-cancer drugs」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|